Paper · 21150893
A novel, non-stop mutation in FOXE3 causes an autosomal dominant form of variable anterior segment dysgenesis including Peters anomaly.
Doucette L and 5 others. Eur J Hum Genet, 2011. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A novel, non-stop mutation in FOXE3 causes an autosomal dominant form of variable anterior segment dysgenesis including Peters anomaly. Papers, record 21150893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21150893
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A novel, non-stop mutation in FOXE3 causes an autosomal dominant form of variable anterior segment dysgenesis including Peters anomaly.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Forkhead Transcription Factors | Major topic |
| Point Mutation | Major topic |
| Adult | |
| Aged | |
| Alleles | |
| Anterior Eye Segment | |
| Cataract | |
| Child | |
| Corneal Opacity | |
| Eye Abnormalities | |
| Female | |
| Follow-Up Studies | |
| Haploinsufficiency | |
| Humans | |
| Lens, Crystalline | |
| Male | |
| Middle Aged | |
| Newfoundland and Labrador | |
| Phenotype | |
| Sequence Analysis, DNA | |
| Young Adult |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,798,333 | Mutation analysis of B3GALTL in Peters Plus syndrome. | Am J Med Genet A | 2008 | https://conductscience.org/library/papers/18798333 | PubMed |
| 2 | 16,604,058 | Novel mutations in GJA8 associated with autosomal dominant congenital cataract and microcornea. | Mol Vis | 2006 | https://conductscience.org/library/papers/16604058 | PubMed |
| 3 | 10,051,017 | A mutation in the RIEG1 gene associated with Peters' anomaly. | J Med Genet | 1999 | https://conductscience.org/library/papers/10051017 | PubMed |
| 4 | 10,080,188 | Prox1 function is crucial for mouse lens-fibre elongation. | Nat Genet | 1999 | https://conductscience.org/library/papers/10080188 | PubMed |
| 5 | 19,708,017 | Seeing clearly: the dominant and recessive nature of FOXE3 in eye developmental anomalies. | Hum Mutat | 2009 | https://conductscience.org/library/papers/19708017 | PubMed |
| 6 | 17,106,362 | Novel CYP1B1 and known PAX6 mutations in anterior segment dysgenesis (ASD). | J Glaucoma | 2006 | https://conductscience.org/library/papers/17106362 | PubMed |
| 7 | 8,162,071 | Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. | Nat Genet | 1994 | https://conductscience.org/library/papers/8162071 | PubMed |
| 8 | 16,636,655 | The PITX3 gene in posterior polar congenital cataract in Australia. | Mol Vis | 2006 | https://conductscience.org/library/papers/16636655 | PubMed |
| 9 | 17,724,170 | Genetic heterogeneity in microcornea-cataract: five novel mutations in CRYAA, CRYGD, and GJA8. | Invest Ophthalmol Vis Sci | 2007 | https://conductscience.org/library/papers/17724170 | PubMed |
| 10 | 11,403,040 | Phenotypic heterogeneity of CYP1B1: mutations in a patient with Peters' anomaly. | J Med Genet | 2001 | https://conductscience.org/library/papers/11403040 | PubMed |
1 to 10 of 34
See all 34 referencesCited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,839,971 | From chromatin to proteostasis: multilevel gene regulation in Mendelian diseases. | Front Epigenet Epigenom | 2026 | https://conductscience.org/library/papers/42839971 | PubMed |
| 42,510,817 | Beyond Coding Variants: RNA-Level Mechanisms in Human Disease and Precision Therapeutics. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42510817 | PubMed |
| 41,597,181 | Single-Cell RNA-Seq Reveals Conserved Cellular Communication Mechanisms Governing Ocular Lineage Specification from Human iPS Cells. | Cells | 2026 | https://conductscience.org/library/papers/41597181 | PubMed |
| 41,556,340 | A predictive framework for stop-loss variants with C-terminal extensions. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/41556340 | PubMed |
| 40,427,049 | Genetic Analysis of CYP1B1 and Other Anterior Segment Dysgenesis-Associated Genes in Latvian Cohort of Primary Congenital Glaucoma. | Biomedicines | 2025 | https://conductscience.org/library/papers/40427049 | PubMed |
| 39,448,564 | Suppressive cancer nonstop extension mutations increase C-terminal hydrophobicity and disrupt evolutionarily conserved amino acid patterns. | Nat Commun | 2024 | https://conductscience.org/library/papers/39448564 | PubMed |
| 39,097,141 | Congenital anterior segment ocular disorders: Genotype-phenotype correlations and emerging novel mechanisms. | Prog Retin Eye Res | 2024 | https://conductscience.org/library/papers/39097141 | PubMed |
| 33,273,802 | A mutation in DOP1B identified as a probable cause for autosomal recessive Peters anomaly in a consanguineous family. | Mol Vis | 2020 | https://conductscience.org/library/papers/33273802 | PubMed |
| 32,719,554 | A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradation. | Nat Cell Biol | 2020 | https://conductscience.org/library/papers/32719554 | PubMed |
| 30,762,128 | Genetics of anophthalmia and microphthalmia. Part 1: Non-syndromic anophthalmia/microphthalmia. | Hum Genet | 2019 | https://conductscience.org/library/papers/30762128 | PubMed |
1 to 10 of 27
See all 27 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FOXE3 | 2,301 | PubTator's text mining | https://conductscience.org/library/genes/2301 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21150893
GET https://conductscience.org/api/papers/v1/21150893/references?page=2